Bernhard Hemmer
Cited by
Cited by
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Nature 476 (7359), 214-219, 2011
Ocrelizumab versus placebo in primary progressive multiple sclerosis
X Montalban, SL Hauser, L Kappos, DL Arnold, A Bar-Or, G Comi, ...
New england journal of medicine 376 (3), 209-220, 2017
Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis
SL Hauser, A Bar-Or, G Comi, G Giovannoni, HP Hartung, B Hemmer, ...
New England Journal of Medicine 376 (3), 221-234, 2017
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
International IBD Genetics Consortium (IIBDGC), C Agliardi, L Alfredsson, ...
Nature genetics 45 (11), 1353-1360, 2013
An automated tool for detection of FLAIR-hyperintense white-matter lesions in multiple sclerosis
P Schmidt, C Gaser, M Arsic, D Buck, A Förschler, A Berthele, M Hoshi, ...
Neuroimage 59 (4), 3774-3783, 2012
ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis
X Montalban, R Gold, AJ Thompson, S Otero-Romero, MP Amato, ...
Multiple Sclerosis Journal 24 (2), 96-120, 2018
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
International Multiple Sclerosis Genetics Consortium*†, ANZgene, ...
Science 365 (6460), eaav7188, 2019
New concepts in the immunopathogenesis of multiple sclerosis
B Hemmer, JJ Archelos, HP Hartung
Nature Reviews Neuroscience 3 (4), 291-301, 2002
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients
S Jarius, K Ruprecht, B Wildemann, T Kuempfel, M Ringelstein, C Geis, ...
Journal of neuroinflammation 9, 1-17, 2012
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
CE Teunissen, A Petzold, JL Bennett, FS Berven, L Brundin, M Comabella, ...
Neurology 73 (22), 1914-1922, 2009
Role of the innate and adaptive immune responses in the course of multiple sclerosis
B Hemmer, M Kerschensteiner, T Korn
The Lancet Neurology 14 (4), 406-419, 2015
Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment
M Krumbholz, D Theil, S Cepok, B Hemmer, P Kivisäkk, RM Ransohoff, ...
Brain 129 (1), 200-211, 2006
Intrathecal pathogenic anti–aquaporin‐4 antibodies in early neuromyelitis optica
JL Bennett, C Lam, SR Kalluri, P Saikali, K Bautista, C Dupree, ...
Annals of Neurology: Official Journal of the American Neurological …, 2009
EFNS guidelines on diagnosis and management of neuromyelitis optica
J Sellner, M Boggild, M Clanet, RQ Hintzen, Z Illes, X Montalban, ...
European journal of neurology 17 (8), 1019-1032, 2010
TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways
I Štefanová, B Hemmer, M Vergelli, R Martin, WE Biddison, RN Germain
Nature immunology 4 (3), 248-254, 2003
Immune surveillance in multiple sclerosis patients treated with natalizumab
O Stüve, CM Marra, KR Jerome, L Cook, PD Cravens, S Cepok, ...
Annals of Neurology: Official Journal of the American Neurological …, 2006
Acute disseminated encephalomyelitis: an update
T Menge, B Hemmer, S Nessler, H Wiendl, O Neuhaus, HP Hartung, ...
Archives of neurology 62 (11), 1673-1680, 2005
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis
A Petzold, LJ Balcer, PA Calabresi, F Costello, TC Frohman, EM Frohman, ...
The Lancet Neurology 16 (10), 797-812, 2017
Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis
S Cepok, D Zhou, R Srivastava, S Nessler, S Stei, K Büssow, N Sommer, ...
The Journal of clinical investigation 115 (5), 1352-1360, 2005
Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis
S Cepok, B Rosche, V Grummel, F Vogel, D Zhou, J Sayn, N Sommer, ...
Brain 128 (7), 1667-1676, 2005
The system can't perform the operation now. Try again later.
Articles 1–20